| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. | SVP & CHIEF TECHNICAL OFFICER | Common Stock | 45.7K | $702K | $15.37 | Aug 28, 2024 | By Toluha ApS |
| Y-mAbs Therapeutics, Inc. | SVP & CHIEF TECHNICAL OFFICER | Common Stock | 35.6K | $547K | $15.37 | Aug 28, 2024 | Direct |
| Y-mAbs Therapeutics, Inc. | SVP & CHIEF TECHNICAL OFFICER | Employee Stock Option (right to buy) | 100K | Aug 28, 2024 | Direct | ||
| Y-mAbs Therapeutics, Inc. | SVP & CHIEF TECHNICAL OFFICER | Employee Stock Option (right to buy) | 35.7K | Jan 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| YMAB | Y-mAbs Therapeutics, Inc. | Aug 28, 2024 | 3 | -$550K | 4 | Aug 30, 2024 | SVP & CHIEF TECHNICAL OFFICER |
| YMAB | Y-mAbs Therapeutics, Inc. | Jan 18, 2024 | 2 | $0 | 4 | Jan 22, 2024 | SVP & CHIEF TECHNICAL OFFICER |
| YMAB | Y-mAbs Therapeutics, Inc. | Jan 26, 2023 | 1 | $0 | 4 | Jan 30, 2023 | SVP & CHIEF TECHNICAL OFFICER |
| YMAB | Y-mAbs Therapeutics, Inc. | Jan 17, 2023 | 2 | $0 | 4 | Jan 19, 2023 | SVP & CHIEF TECHNICAL OFFICER |
| YMAB | Y-mAbs Therapeutics, Inc. | Apr 26, 2022 | 1 | $0 | 4 | Apr 28, 2022 | SVP & CTO |
| YMAB | Y-mAbs Therapeutics, Inc. | Dec 14, 2021 | 1 | $0 | 4 | Dec 16, 2021 | SVP & CTO |